372 related articles for article (PubMed ID: 27473326)
1. Impact of intra-operative cell salvage on blood coagulation in high-bleeding-risk patients undergoing cardiac surgery with cardiopulmonary bypass: a prospective randomized and controlled trial.
Shen S; Zhang J; Wang W; Zheng J; Xie Y
J Transl Med; 2016 Jul; 14(1):228. PubMed ID: 27473326
[TBL] [Abstract][Full Text] [Related]
2. The efficacy, safety and cost-effectiveness of intra-operative cell salvage in high-bleeding-risk cardiac surgery with cardiopulmonary bypass: a prospective randomized and controlled trial.
Xie Y; Shen S; Zhang J; Wang W; Zheng J
Int J Med Sci; 2015; 12(4):322-8. PubMed ID: 25897293
[TBL] [Abstract][Full Text] [Related]
3. A comparison of haemostatic biomarkers during low-risk patients undergoing cardiopulmonary bypass using either conventional centrifugal cell salvage or the HemoSep device.
Boyle G; Kuffel A; Parmar K; Gibson K; Smith M; Grehan A; Hunt BJ; Chambers DJ
Perfusion; 2019 Jan; 34(1):76-83. PubMed ID: 30067140
[TBL] [Abstract][Full Text] [Related]
4. The Effects of Steroids on Coagulation Dysfunction Induced by Cardiopulmonary Bypass: A Steroids in Cardiac Surgery (SIRS) Trial Substudy.
Paparella D; Parolari A; Rotunno C; Vincent J; Myasoedova V; Guida P; De Palo M; Margari V; Devereaux PJ; Lamy A; Alamanni F; Yusuf S; Whitlock R
Semin Thorac Cardiovasc Surg; 2017 Spring; 29(1):35-44. PubMed ID: 28683994
[TBL] [Abstract][Full Text] [Related]
5. Plasma fibrinogen level on admission to the intensive care unit is a powerful predictor of postoperative bleeding after cardiac surgery with cardiopulmonary bypass.
Kindo M; Hoang Minh T; Gerelli S; Perrier S; Meyer N; Schaeffer M; Bentz J; Announe T; Mommerot A; Collange O; Pottecher J; Cristinar M; Thiranos JC; Gros H; Mertes PM; Billaud P; Mazzucotelli JP
Thromb Res; 2014 Aug; 134(2):360-8. PubMed ID: 24857189
[TBL] [Abstract][Full Text] [Related]
6. Excessive postoperative bleeding and outcomes in neonates undergoing cardiopulmonary bypass.
Guzzetta NA; Allen NN; Wilson EC; Foster GS; Ehrlich AC; Miller BE
Anesth Analg; 2015 Feb; 120(2):405-10. PubMed ID: 25390280
[TBL] [Abstract][Full Text] [Related]
7. Prothrombin Complex Concentrate vs Plasma for Post-Cardiopulmonary Bypass Coagulopathy and Bleeding: A Randomized Clinical Trial.
Smith MM; Schroeder DR; Nelson JA; Mauermann WJ; Welsby IJ; Pochettino A; Montonye BL; Assawakawintip C; Nuttall GA
JAMA Surg; 2022 Sep; 157(9):757-764. PubMed ID: 35767271
[TBL] [Abstract][Full Text] [Related]
8. Thromboelastography is a suboptimal test for determination of the underlying cause of bleeding associated with cardiopulmonary bypass and may not predict a hypercoagulable state.
Welsh KJ; Padilla A; Dasgupta A; Nguyen AN; Wahed A
Am J Clin Pathol; 2014 Oct; 142(4):492-7. PubMed ID: 25239416
[TBL] [Abstract][Full Text] [Related]
9. Association of blood products administration during cardiopulmonary bypass and excessive post-operative bleeding in pediatric cardiac surgery.
Agarwal HS; Barrett SS; Barry K; Xu M; Saville BR; Donahue BS; Harris ZL; Bichell DP
Pediatr Cardiol; 2015 Mar; 36(3):459-67. PubMed ID: 25293425
[TBL] [Abstract][Full Text] [Related]
10. Predictors of postoperative bleeding in children undergoing cardiopulmonary bypass: A preliminary Italian study.
Spiezia L; Di Gregorio G; Campello E; Maggiolo S; Bortolussi G; Stellin G; Simioni P; Vida V
Thromb Res; 2017 May; 153():85-89. PubMed ID: 28359027
[TBL] [Abstract][Full Text] [Related]
11. The influence of perioperative coagulation status on postoperative blood loss in complex cardiac surgery: a prospective observational study.
Karkouti K; McCluskey SA; Syed S; Pazaratz C; Poonawala H; Crowther MA
Anesth Analg; 2010 Jun; 110(6):1533-40. PubMed ID: 20435945
[TBL] [Abstract][Full Text] [Related]
12. Managing the coagulopathy associated with cardiopulmonary bypass.
Bartoszko J; Karkouti K
J Thromb Haemost; 2021 Mar; 19(3):617-632. PubMed ID: 33251719
[TBL] [Abstract][Full Text] [Related]
13. Effect of priming solution and ultrafiltration on post-operative bleeding and blood transfusion in cardiac surgery. Randomized controlled trial.
Olmos Rodríguez M; Ballester Hernández JA; Arteta Bárcenas MT; Rodríguez Cerezo A; Vidarte Ortiz de Artiñano MA; Veiga Alameda C
Rev Esp Anestesiol Reanim; 2015 Feb; 62(2):81-9. PubMed ID: 25048999
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of recombinant factor XIII on reducing blood transfusions in cardiac surgery: a randomized, placebo-controlled, multicenter clinical trial.
Karkouti K; von Heymann C; Jespersen CM; Korte W; Levy JH; Ranucci M; Sellke FW; Song HK
J Thorac Cardiovasc Surg; 2013 Oct; 146(4):927-39. PubMed ID: 23820174
[TBL] [Abstract][Full Text] [Related]
15. The prothrombotic paradox of severe obesity after cardiac surgery under cardiopulmonary bypass.
Kindo M; Minh TH; Gerelli S; Meyer N; Schaeffer M; Perrier S; Bentz J; Announe T; Mommerot A; Collange O; Marguerite S; Thibaud A; Gros H; Billaud P; Mazzucotelli JP
Thromb Res; 2014 Aug; 134(2):346-53. PubMed ID: 24972846
[TBL] [Abstract][Full Text] [Related]
16. Blood coagulation and autologous blood transfusion in cardiac surgery.
Inada E
J Clin Anesth; 1990; 2(6):393-406. PubMed ID: 2271204
[TBL] [Abstract][Full Text] [Related]
17. Association Between Platelet Count and Postoperative Blood Loss in Patients Undergoing Cardiac Surgery With Cardiopulmonary Bypass and Fresh Frozen Plasma Administration Guided by Thromboelastometry.
Ichikawa J; Osada Y; Kodaka M; Nishiyama K; Komori M
Circ J; 2018 Feb; 82(3):677-683. PubMed ID: 29238008
[TBL] [Abstract][Full Text] [Related]
18. The relationship between fibrinogen levels after cardiopulmonary bypass and large volume red cell transfusion in cardiac surgery: an observational study.
Karkouti K; Callum J; Crowther MA; McCluskey SA; Pendergrast J; Tait G; Yau TM; Beattie WS
Anesth Analg; 2013 Jul; 117(1):14-22. PubMed ID: 23687229
[TBL] [Abstract][Full Text] [Related]
19. [Perioperative fibrinogen concentrations in cardiac surgery with cardiopulmonary bypass].
Uji M; Terada Y; Noguchi T; Nishida T; Hasuwa K; Shinohara K; Kumano H; Ishimura N; Nishiwada M
Masui; 2012 Aug; 61(8):814-9. PubMed ID: 22991801
[TBL] [Abstract][Full Text] [Related]
20. A phase 2 prospective, randomized, double-blind trial comparing the effects of tranexamic acid with ecallantide on blood loss from high-risk cardiac surgery with cardiopulmonary bypass (CONSERV-2 Trial).
Bokesch PM; Szabo G; Wojdyga R; Grocott HP; Smith PK; Mazer CD; Vetticaden S; Wheeler A; Levy JH
J Thorac Cardiovasc Surg; 2012 May; 143(5):1022-9. PubMed ID: 21724197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
